An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
A study by the Bloomberg School of Public Health found that severe COVID-19 patients can produce strong antibodies for vaccine testing - especially the older male population.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
